GSEP
PROF

Golden State Equity Partners’s Profound Medical PROF Stock Holding History

Golden State Equity Partners’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,961
Closed -$31.5K – 752
2024
Q3 		$31.5K Buy
+3,961
New +$35.8K 0.02% 452
2022
Q1 		$328K Buy
36,430
+50
+0.1% +$482 0.17% 145
2021
Q4 		$411K Buy
36,380
+5,495
+18% +$68.6K 0.21% 103
2021
Q3 		$450K Buy
30,885
+4,450
+17% +$67.8K 0.18% 125
2021
Q2 		$430K Buy
+26,435
New +$492K 0.17% 139

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Golden State Equity Partners's PROF Position: Q4 2024 in Review

Golden State Equity Partners sold out of Profound Medical (PROF) in Q4 2024, closing a stake of 3,961 shares — an estimated $31.5K sold.

Golden State Equity Partners first reported a position in PROF in Q2 2021 and held it in 5 quarters. The position peaked at $450K in Q3 2021. 52 funds tracked by Wall St. Rank hold PROF as of Q4 2024.

  • Golden State Equity Partners reported no remaining Profound Medical position as of Q4 2024 after selling out during the quarter.
  • Golden State Equity Partners sold 3,961 Profound Medical shares in Q4 2024, an estimated $31.5K.
  • Golden State Equity Partners first reported a position in Profound Medical in Q2 2021 and held it in 5 quarters.
  • Golden State Equity Partners's Profound Medical position peaked at $450K in Q3 2021.
  • 52 funds tracked by Wall St. Rank held Profound Medical as of Q4 2024.

Based on Golden State Equity Partners's 13F filing for Q4 2024, filed 24 Jan 2025.